INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo ASTERIX ALENDRONATE 70 tablet

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
Schedule 3

PROPRIETARY NAME
(and dosage form):

ASTERIX ALENDRONATE 70 tablet

COMPOSITION:
Each tablet contains
alendronate sodium trihydrate equivalent to alendronic acid 70,0 mg

ATC CLASSIFICATION:
no data

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
42/3.2/0410

APPLICANT:
Litha Pharma (Pty) Ltd

MANUFACTURER:
PHARMACEUTICAL WORKS
POLPHARMA SA, STAROGARD, GDANSK', POLAND

AVAILABILITY:
no data - please check with company

DATE OF REGISTRATION:
05 December 2013

SOURCE: Government Gazette - STAATSKOERANT, 13 JUNIE 2014 No. 37727
NOTICE 405 OF 2014 - MEDICINES CONTROL COUNCIL

Date posted: July 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2016